Iezzi G - Search Results

1

The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.

Iezzi G, Rivolta L, Ronchetti A, Martin-Fontecha A, Rosato A, Protti MP, Sabbadini MG, Bellone M. Iezzi G, et al. Cancer Res. 1997 Jul 1;57(13):2564-8. Cancer Res. 1997. PMID: 9205054

2

B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines.

Iezzi G, Protti MP, Rugarli C, Bellone M. Iezzi G, et al. Cancer Res. 1996 Jan 1;56(1):11-5. Cancer Res. 1996. PMID: 8548749

3

Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines.

Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, Protti MP, Garancini MP, Manfredi AA, Rugarli C, Bellone M. Ronchetti A, et al. Among authors: iezzi g. J Immunol. 1999 Jul 1;163(1):130-6. J Immunol. 1999. PMID: 10384108

4

Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells.

Ronchetti A, Iezzi G, Crosti MC, Garancini MP, Protti MP, Bellone M. Ronchetti A, et al. Among authors: iezzi g. J Leukoc Biol. 1999 Aug;66(2):247-51. doi: 10.1002/jlb.66.2.247. J Leukoc Biol. 1999. PMID: 10449162

5

Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

Camporeale A, Boni A, Iezzi G, Degl'Innocenti E, Grioni M, Mondino A, Bellone M. Camporeale A, et al. Among authors: iezzi g. Cancer Res. 2003 Jul 1;63(13):3688-94. Cancer Res. 2003. PMID: 12839960

6

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.

Bellone M, Iezzi G, Manfredi AA, Protti MP, Dellabona P, Casorati G, Rugarli C. Bellone M, et al. Among authors: iezzi g. Eur J Immunol. 1994 Nov;24(11):2691-8. doi: 10.1002/eji.1830241118. Eur J Immunol. 1994. PMID: 7525300

7

Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.

Martin-Fontecha A, Cavallo F, Bellone M, Heltai S, Iezzi G, Tornaghi P, Nabavi N, Forni G, Dellabona P, Casorati G. Martin-Fontecha A, et al. Among authors: iezzi g. Eur J Immunol. 1996 Aug;26(8):1851-9. doi: 10.1002/eji.1830260828. Eur J Immunol. 1996. PMID: 8765031

8

Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cells.

Bellone M, Iezzi G, Martin-Fontecha A, Rivolta L, Manfredi AA, Protti MP, Freschi M, Dellabona P, Casorati G, Rugarli C. Bellone M, et al. Among authors: iezzi g. J Immunol. 1997 Jan 15;158(2):783-9. J Immunol. 1997. PMID: 8992995

9

Processing of engulfed apoptotic bodies yields T cell epitopes.

Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP, Davoust J, Rugarli C, Manfredi AA. Bellone M, et al. Among authors: iezzi g. J Immunol. 1997 Dec 1;159(11):5391-9. J Immunol. 1997. PMID: 9548479

10

Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses.

Iezzi G, Boni A, Degl'Innocenti E, Grioni M, Bertilaccio MT, Bellone M. Iezzi G, et al. J Immunol. 2006 Aug 15;177(4):2131-7. doi: 10.4049/jimmunol.177.4.2131. J Immunol. 2006. PMID: 16887972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters